Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverterdefibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up

Archives of Medical Science

Volumn 6, Issue 6, 2010, Pages 900-903

  Gandhi, Kaushang ^a,b   Aronow, Wilbert S ^a,b   Desai, Harit ^a,b   Amin, Harshad ^a,b   Lai, Hoang M ^a,b   Frishman, William H ^a,b   Cohen, Martin ^a,b   Sorbera, Carmen ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cardioverterdefibrillator shocks; Ischemic cardiomyopathy; Nonischemic cardiomyopathy

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; DEFIBRILLATION; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; SUDDEN DEATH;

EID: 78650209858     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.19299     Document Type: Article

References (15)

1. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-40.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmicdrug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-83.
3. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882-90.
4. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
5. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
6. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158.
7. Ermis C, Zhu AX, Vanheel L, et al. Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators. Am J Cardiol 2005; 96: 233-8.
8. Evonich RF, Maheshwari A, Gardiner JC, et al. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia. J Interv Card Electrophysiol 2004; 11: 59-65.
9. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: 1343-82.
10. Kannam H, Aronow WS, Chilappa K. Association of the QRS duration on the resting electrocardiogram with the severity of coronary artery disease in 2,196 patients undergoing coronary angiography for suspected coronary artery disease. Arch Med Sci 2009; 5: 163-5.
11. Kruger A, Aronow WS, Lai HM, et al. Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverterdefibrillators. Am J Therap 2009; 16: 323-5.
12. Tandri H, Griffith LS, Tang T, et al. Clinical course and longterm follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm 2006; 3: 762-8.
13. Singh JP, Hall WJ, McNitt S, et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia /fibrillation. Findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 2005; 46: 1712-20.
14. Ellenbogen KA, Levine JH, Berger RD, et al. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006; 113: 776-82.
15. Chen HA, Hsia HH, Vagelos R, et al. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2007; 30: 390-4.